EMMA

Emmaus Life Sciences, Inc.
OTC Markets OTCQBUSDEQUITY DELAYED
Last price
0.06
▲ 0.02 (42.65%)
MARKET · —

Price

1D — H — L — Range — Vol —
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
0.04
Day high
0.06
Day low
0.06
Volume
14.45K
Market cap
—
P/E (TTM)
—
52W range
0.01 – 0.09

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
-7.97% -9.9%
1M
+0.15% -1.3%
3M
+442.70% +439.3%
6M
+496.44% +481.5%
YTD
+363.38% +349.4%
1Y
+424.74% +409.0%
3Y
-51.81% -133.7%
5Y
— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Free account

3 more panels on EMMA open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Fundamentals

TTM · reported
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—

Valuation & profitability ratios

Account required
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 4 years · 6 quarters
Blank means not reported, not zero
Line item2025202420232022YoY
Total revenue $12.45M$16.65M$29.60M$18.39M -25.2%
Operating revenue $12.23M$16.15M$28.96M$17.85M -24.3%
Cost of revenue $857.00K$1.20M$1.34M$2.59M -28.6%
Gross profit $11.60M$15.45M$28.25M$15.80M -25.0%
Research & development $313.00K$657.00K$1.19M$1.73M -52.4%
Selling, general & admin $11.05M$16.69M$23.53M$20.66M -33.8%
Total operating expense $11.37M$17.35M$24.71M$22.39M -34.5%
Operating income $231.00K-$1.89M$3.54M-$6.59M +112.2%
Net interest income -$6.86M-$5.21M-$6.70M-$4.33M -31.6%
Pre-tax income -$7.48M-$6.42M-$3.79M-$10.56M -16.5%
Tax provision $9.00K$29.00K-$59.00K$60.00K -69.0%
Net income -$7.49M-$6.45M-$3.73M-$10.63M -16.1%
Net income to common -$7.49M-$6.45M-$3.73M-$10.63M -16.1%
Basic EPS -0.12-0.10-0.07-0.21 -20.0%
Diluted EPS -0.12-0.10-0.07-0.21 -20.0%
EBIT -$349.00K-$932.00K$3.59M-$5.55M +62.6%
EBITDA -$310.00K-$910.00K$3.62M-$5.50M +65.9%
Basic shares 64.04M63.23M53.11M49.44M +1.3%
Diluted shares 64.04M63.23M53.11M49.44M +1.3%

Analyst targets & ownership

Account required
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
0.06
-2.15% from price
SMA 20
0.06
-0.72% from price
SMA 50
0.04
+43.78% from price
SMA 100
0.03
+128.02% from price
SMA 200
0.02
+207.87% from price
EMA 12
0.06
-0.05% from price
EMA 26
0.06
+6.75% from price
EMA 50
0.05
+29.33% from price
RSI (14)
52.8
Neutral
MACD (12,26,9)
0.00
Hist -0.00
ATR (14)
0.01
13.07% of price
Realised vol 30D
281.8%
Annualised
Bollinger upper
0.07
20, 2σ
Bollinger lower
0.05
20, 2σ
50 / 200 cross
Golden
0.04 vs 0.02
Trend bias
Above 200
+207.87%

Options chain

Account required
Expiry
Spot 0.06
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
-0.13
Less volatile than market
Correlation to SPY
-0.01
Largely independent
Realised vol 30D
281.8%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-51.2%
Peak to trough
Max drawdown 5Y
-100.0%
Peak to trough
ATR 14
0.01
13.07% of price
Beta (reported)
—
5Y monthly, from filing

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.